Erratum: Effects of daily consumption of synbiotic bread on insulin metabolism and serum high-sensitivity c-reactive protein among diabetic patients: A double-blind, randomized, controlled clinical trial (Annals of Nutrition and Metabolism (2014) 65:1 (34-41) DOI: 10.1159/000365153);Effects of daily consumption of synbiotic bread on insulin metabolism and serum high-sensitivity c-reactive protein among diabetic patients: A double-blind, randomized, controlled clinical trial

Annals of Nutrition and Metabolism

Volumn 65, Issue 1, 2014, Pages 34-41

  Tajadadi Ebrahimi, Maryam ^a   Bahmani, Fereashteh ^c   Shakeri, Hossein ^c   Hadaegh, Haleh ^b   Hijijafari, Mohammad ^c   Abedi, Fatemeh ^c   Asemi, Zatollah ^c  

^a ISLAMIC AZAD UNIVERSITY   (Iran)

^b Sahar Bread Company   (Iran)

^c KASHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Diabetes; Insulin metabolism; Probiotic; Synbiotic

Indexed keywords

C REACTIVE PROTEIN; PROBIOTIC AGENT; SYNBIOTIC AGENT; GLUCOSE BLOOD LEVEL; INSULIN;

ADULT; ARTICLE; BLOOD SAMPLING; BREAD; CELL FUNCTION; CONTROLLED STUDY; DIABETIC PATIENT; DOUBLE BLIND PROCEDURE; FEMALE; FOOD INTAKE; HOMEOSTASIS; HUMAN; INSULIN BLOOD LEVEL; INSULIN METABOLISM; LACTOBACILLUS; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; PROTEIN BLOOD LEVEL; QUANTITATIVE INSULIN SENSITIVITY CHECK INDEX; RANDOMIZED CONTROLLED TRIAL; ANALYSIS; BLOOD; DIABETES MELLITUS, TYPE 2; GLUCOSE BLOOD LEVEL; INSULIN RESISTANCE; IRAN; METABOLISM; MICROBIOLOGY;

BLOOD GLUCOSE; BREAD; C-REACTIVE PROTEIN; DIABETES MELLITUS, TYPE 2; DOUBLE-BLIND METHOD; FEMALE; HUMANS; INSULIN; INSULIN RESISTANCE; IRAN; LACTOBACILLUS; MALE; MIDDLE AGED; PROBIOTICS; SYNBIOTICS;

EID: 84908582656     PISSN: 02506807     EISSN: 14219697     Source Type: Journal    
DOI: 10.1159/000529288     Document Type: Erratum

References (39)

1. Lin L, Saha PK, Ma X, Henshaw IO, Shao L, Chang BH, Buras ED, Tong Q, Chan L, Mc- Guinness OP, Sun Y: Ablation of ghrelin receptor reduces adiposity and improves insulin sensitivity during aging by regulating fat metabolism in white and brown adipose tissues. Aging Cell 2011; 10: 996-1010.
2. Lontchi-Yimagou E, Sobngwi E, Matsha TE, Kengne AP: Diabetes mellitus and inflammation. Curr Diab Rep 2013; 13: 435-444.
3. Yadav H, Jain S, Sinha PR: Antidiabetic effect of probiotic dahi containing Lactobacillus acidophilus and Lactobacillus casei in high fructose fed rats. Nutrition 2007; 23: 62-68.
4. Kawamoto R, Tabara Y, Kohara K, Miki T, Kusunoki T, Takayama S, Abe M, Katoh T, Ohtsuka N: Relationships between lipid profiles and metabolic syndrome, insulin resistance and serum high molecular adiponectin in Japanese community-dwelling adults. Lipids Health Dis 2011; 10: 79.
5. Fiehn O, Garvey WT, Newman JW, Lok KH, Hoppel CL, Adams SH: Plasma metabolomic profiles reflective of glucose homeostasis in non-diabetic and type 2 diabetic obese African-American women. PLoS One 2010; 5:e15234.
6. Kusminski CM, Shetty S, Orci L, Unger RH, Scherer PE: Diabetes and apoptosis: lipotoxicity. Apoptosis 2009; 14: 1484-1495.
7. Raz I, Eldor R, Cernea S, Shafrir E: Diabetes: insulin resistance and derangements in lipid metabolism: cure through intervention in fat transport and storage. Diabetes Metab Res Rev 2005; 21: 3-14.
8. Aronne LJ, Pagotto U, Foster GD, Davis SN: The endocannabinoid system as a target for obesity treatment. Clin Cornerstone 2008; 9: 52-64, discussion 65-66.
9. Jacob S, Klimm HJ, Rett K, Helsberg K, Haring HU, Godicke J: Effects of moxonidine vs. metoprolol on blood pressure and metabolic control in hypertensive subjects with type 2 diabetes. Exp Clin Endocrinol Diabetes 2004; 112: 315-322.
10. Eschwege E: The dysmetabolic syndrome, insulin resistance and increased cardiovascular (CV) morbidity and mortality in type 2 diabetes: aetiological factors in the development of CV complications. Diabetes Metab 2003; 29: 6S19-6S27.
11. Pedicino D, Liuzzo G, Trotta F, Giglio AF, Giubilato S, Martini F, Zaccardi F, Scavone G, Previtero M, Massaro G, Cialdella P, Cardillo MT, Pitocco D, Ghirlanda G, Crea F: Adaptive immunity, inflammation, and cardiovascular complications in type 1 and type 2 diabetes mellitus. J Diabetes Res 2013; 2013: 184258.
12. Farvid MS, Homayouni F, Shokoohi M, Fallah A: Glycemic index, glycemic load and their association with glycemic control among patients with type 2 diabetes. Eur J Clin Nutr 2014; 68: 459-463.
13. Chorell E, Svensson MB, Moritz T, Antti H: Physical fitness level is reflected by alterations in the human plasma metabolome. Mol Biosyst 2012; 8: 1187-1196.
14. Picot J, Jones J, Colquitt JL, Gospodarevskaya E, Loveman E, Baxter L, Clegg AJ: The clinical effectiveness and cost-effectiveness of bariatric (weight loss) surgery for obesity: a systematic review and economic evaluation. Health Technol Assess 2009; 13: 1-190, 215-357, iii-iv.
15. Gonzalez-Ortiz M, Martinez-Abundis E, Robles-Cervantes JA, Ramirez-Ramirez V, Ramos-Zavala MG: Effect of thiamine administration on metabolic profile, cytokines and inflammatory markers in drug-naive patients with type 2 diabetes. Eur J Nutr 2011; 50: 145-149.
16. Ripsin CM, Kang H, Urban RJ: Management of blood glucose in type 2 diabetes mellitus. Am Fam Physician 2009; 79: 29-36.
17. Asemi Z, Jazayeri S, Najafi M, Samimi M, Mofid V, Shidfar F, Foroushani AR, Shahaboddin ME: Effects of daily consumption of probiotic yoghurt on inflammatory factors in pregnant women: a randomized controlled trial. Pak J Biol Sci 2011; 14: 476-482.
18. Raso GM, Simeoli R, Iacono A, Santoro A, Amero P, Paciello O, Russo R, D'Agostino G, Di Costanzo M, Canani RB, Calignano A, Meli R: Effects of a Lactobacillus paracasei B21060 based synbiotic on steatosis, insulin signaling and Toll-like receptor expression in rats fed a high-fat diet. J Nutr Biochem 2014; 25: 81-90.
19. Asemi Z, Khorrami-Rad A, Alizadeh SA, Shakeri H, Esmaillzadeh A: Effects of synbiotic food consumption on metabolic status of diabetic patients: a double-blind randomized cross-over controlled clinical trial. Clin Nutr 2014; 33: 198-203.
20. Asemi Z, Zare Z, Shakeri H, Sabihi S-S, Esmaillzadeh A: Effect of multispecies probiotic supplements on metabolic profile, hs-CRP and oxidative stress in patients with type 2 diabetes. Ann Nutr Metab 2013; 63: 1-9.
21. Vitali B, Ndagijimana M, Cruciani F, Carnevali P, Candela M, Guerzoni ME, Brigidi P: Impact of a synbiotic food on the gut microbial ecology and metabolic profiles. BMC Microbiol 2010; 10: 4.
22. Yadav H, Lee JH, Lloyd J, Walter P, Rane SG: Beneficial metabolic effects of a probiotic via butyrate induced GLP-1 secretion. J Biol Chem 2013; 288: 25088-25097.
23. Voltolini C, Battersby S, Etherington SL, Petraglia F, Norman JE, Jabbour HN: A novel antiinflammatory role for the short-chain fatty acids in human labor. Endocrinology 2012; 153: 395-403.
24. Mazloom Z, Yousefinejad A, Dabbaghmanesh MH: Effect of probiotics on lipid profile, glycemic control, insulin action, oxidative stress, and inflammatory markers in patients with type 2 diabetes: a clinical trial. Iran J Med Sci 2013; 38: 38-43.
25. American Diabetes Association: Diagnosis and classification of diabetes mellitus. Diabetes Care 2012; 35(suppl 1):S64-S71.
26. Pisprasert V, Ingram KH, Lopez-Davila MF, Munoz AJ, Garvey WT: Limitations in the use of indices using glucose and insulin levels to predict insulin sensitivity: impact of race and gender and superiority of the indices derived from oral glucose tolerance test in African Americans. Diabetes Care 2013; 36: 845-853.
27. Endres JR, Clewell A, Jade KA, Farber T, Hauswirth J, Schauss AG: Safety assessment of a proprietary preparation of a novel probiotic, Bacillus coagulans, as a food ingredient. Food Chem Toxicol 2009; 47: 1231-1238.
28. Krentz AJ: Lipoprotein abnormalities and their consequences for patients with type 2 diabetes. Diabetes Obes Metab 2003; 5(suppl 1): S19-S27.
29. Andreasen AS, Larsen N, Pedersen-Skovsgaard T, Berg RM, Moller K, Svendsen KD, Jakobsen M, Pedersen BK: Effects of Lactobacillus acidophilus NCFM on insulin sensitivity and the systemic inflammatory response in human subjects. Br J Nutr 2010; 104: 1831-1838.
30. Asemi Z, Samimi M, Tabassi Z, Naghibi Rad M, Rahimi Foroushani A, Khorammian H, Esmaillzadeh A: Effect of daily consumption of probiotic yoghurt on insulin resistance in pregnant women: a randomized controlled trial. Eur J Clin Nutr 2013; 67: 71-74.
31. Tripolt NJ, Leber B, Blattl D, Eder M, Wonisch W, Scharnagl H, Stojakovic T, Obermayer- Pietsch B, Wascher TC, Pieber TR, Stadlbauer V, Sourij H: Short communication: effect of supplementation with Lactobacillus casei Shirota on insulin sensitivity, beta-cell function, and markers of endothelial function and inflammation in subjects with metabolic syndrome - a pilot study. J Dairy Sci 2013; 96: 89-95.
32. Esteve E, Ricart W, Fernandez-Real JM: Gut microbiota interactions with obesity, insulin resistance and type 2 diabetes: did gut microbiote co-evolve with insulin resistance? Curr Opin Clin Nutr Metab Care 2011; 14: 483-490.
33. Diamant M, Blaak EE, de Vos WM: Do nutrient- gut-microbiota interactions play a role in human obesity, insulin resistance and type 2 diabetes? Obes Rev 2011; 12: 272-281.
34. Caricilli AM, Picardi PK, de Abreu LL, Ueno M, Prada PO, Ropelle ER, Hirabara SM, Castoldi A, Vieira P, Camara NO, Curi R, Carvalheira JB, Saad MJ: Gut microbiota is a key modulator of insulin resistance in TLR 2 knockout mice. PLoS Biol 2011; 9:e1001212.
35. Holma R, Kekkonen RA, Hatakka K, Poussa T, Vapaatalo H, Adlercreutz H, Korpela R: Low serum enterolactone concentration is associated with low colonic Lactobacillus-Enterococcus counts in men but is not affected by a synbiotic mixture in a randomised, placebocontrolled, double-blind, cross-over intervention study. Br J Nutr 2014; 111: 301-309.
36. Bourreille A, Cadiot G, Le Dreau G, Laharie D, Beaugerie L, Dupas JL, Marteau P, Rampal P, Moyse D, Saleh A, Le Guern ME, Galmiche JP: Saccharomyces boulardii does not prevent relapse of Crohn's disease. Clin Gastroenterol Hepatol 2013; 11: 982-987.
37. Hatakka K, Martio J, Korpela M, Herranen M, Poussa T, Laasanen T, Saxelin M, Vapaatalo H, Moilanen E, Korpela R: Effects of probiotic therapy on the activity and activation of mild rheumatoid arthritis - a pilot study. Scand J Rheumatol 2003; 32: 211-215.
38. Sugawara G, Nagino M, Nishio H, Ebata T, Takagi K, Asahara T, Nomoto K, Nimura Y: Perioperative synbiotic treatment to prevent postoperative infectious complications in biliary cancer surgery: a randomized controlled trial. Ann Surg 2006; 244: 706-714.
39. Giamarellos-Bourboulis EJ, Bengmark S, Kanellakopoulou K, Kotzampassi K: Pro- and synbiotics to control inflammation and infection in patients with multiple injuries. J Trauma 2009; 67: 815-821.